GlobeNewswire: Pomerantz LLP Contains the last 10 of 12849 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T14:28:00ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/27/2853388/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-Integra-Lifesciences-Holdings-Corp-IART.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART2024-03-27T15:49:12Z<![CDATA[NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating whether the Board of Directors of Integra Lifesciences Holdings Corp (NASDAQ: IART) (“Integra”) potentially breached their fiduciary duties to shareholders. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/27/2853386/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-Sotera-Health-Company-SHC.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sotera Health Company - SHC2024-03-27T15:43:57Z<![CDATA[NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating whether the Board of Directors of Sotera Health Company (NASDAQ: SHC) (“Sotera”) potentially breached their fiduciary duties to shareholders. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/23/2851291/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Announces-the-Filing-of-a-Class-Action-Against-Lyft-Inc-LYFT.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Lyft, Inc. - LYFT2024-03-23T20:51:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lyft, Inc. (“Lyft” or the “Company”) (NASDAQ: LYFT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.]]>https://www.globenewswire.com/news-release/2024/03/23/2851290/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-PSQ-Holdings-Inc-PSQH.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PSQ Holdings, Inc. - PSQH2024-03-23T20:50:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PSQ Holdings, Inc. (“PSQ” or the “Company”) (NYSE: PSQH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/23/2851289/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-Enfusion-Inc-ENFN.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN2024-03-23T20:49:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (“Enfusion” or the “Company”) (NYSE: ENFN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/23/2851288/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-Spruce-Biosciences-Inc-SPRB.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB2024-03-23T20:48:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. (“Spruce” or the “Company”) (NASDAQ: SPRB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/23/2851287/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-Luna-Innovations-Incorporated-LUNA.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Luna Innovations Incorporated - LUNA2024-03-23T20:46:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Luna Innovations Incorporated (“Luna” or the “Company”) (NASDAQ: LUNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/23/2851286/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-Bristol-Myers-Squibb-Company-BMY.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY2024-03-23T20:45:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bristol-Myers Squibb Company (“Bristol Myers” or the “Company”) (NYSE: BMY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/23/2851285/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Comtech-Telecommunications-Corp-CMTL.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Comtech Telecommunications Corp. - CMTL2024-03-23T20:44:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Comtech Telecommunications Corp. (“Comtech” or the “Company”) (NASDAQ: CMTL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>https://www.globenewswire.com/news-release/2024/03/23/2851284/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-on-Behalf-of-Investors-of-Fair-Isaac-Corporation-FICO.html?f=22&fvtc=4&fvtv=701SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fair Isaac Corporation- FICO2024-03-23T20:43:00Z<![CDATA[NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fair Isaac Corporation (“FICO” or the “Company”) (NYSE: FICO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.]]>